

Co-promotes SSK Biosciences and Vannsh Lifesciences at CPHI under the ARBROWN banner. SSK offers agile CDMO support, process development, GMP manufacturing and analytical services, while Vannsh focuses on high-potency oncology APIs such as Ibrutinib, Osimertinib, Venetoclax, Abemaciclib, Dabrafenib and Ribociclib, backed by global filings. ARBROWN connects trusted partners across Asia, Europe and beyond.

Aucun commentaire disponible.
Laissez votre note & commentaire